Article
Management of Sleep Disturbances Associated with Smith-Magenis Syndrome.
CNS drugs - 1 Jul 2020
Kaplan Kevin A, Elsea Sarah H, Potocki Lorraine
Abstract excerpt
Smith-Magenis syndrome is a genetic disorder caused by a microdeletion involving the retinoic acid-induced 1 (RAI1) gene that maps on the short arm of chromosome 17p11.2 or a pathogenic mutation of RAI1. Smith-Magenis syndrome affects patients through numerous congenital anomalies, intellectual disabilities, behavioral challenges, and sleep disturbances. The sleep abnormalities associated with Smith-Magenis...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
